Advancing Treatment for NRG1 Fusion+ Lung and Pancreatic Cancers - Episode 9
E. Gabriela Chiorean, MD, of Fred Hutch Cancer Center, discusses the recent clinical data with zenocutuzumab in patients with NRG1 fusion–positive pancreatic cancer and the impact the approval of this agent could have on the landscape.